Development and validation of a prognostic 15-gene signature for stratifying HER2+/ER+ breast cancer

BACKGROUND: Human epidermal growth receptor 2-positive (HER2+) breast cancer (BC) is a heterogeneous subgroup. Estrogen receptor (ER) status is emerging as a predictive marker within HER2+ BCs, with the HER2+/ER+ cases usually having better survival in the first 5 years after diagnosis but have high...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qian, Huang, Shujun, Desautels, Danielle, McManus, Kirk J., Murphy, Leigh, Hu, Pingzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196919/
https://www.ncbi.nlm.nih.gov/pubmed/37216014
http://dx.doi.org/10.1016/j.csbj.2023.05.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196919/
https://www.ncbi.nlm.nih.gov/pubmed/37216014
http://dx.doi.org/10.1016/j.csbj.2023.05.002

Ejemplares similares